XML 40 R9.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
REPOSITIONING AND OTHER CHARGES
12 Months Ended
Dec. 31, 2019
Restructuring and Related Activities [Abstract]  
Repositioning and Other Charges Repositioning and Other Charges
A summary of repositioning and other charges follows:
 
Years Ended December 31,
2019
 
2018
 
2017
Severance
$
260

 
$
289

 
$
305

Asset impairments
95

 
162

 
142

Exit costs
83

 
79

 
60

Reserve adjustments
(5
)
 
(10
)
 
(16
)
Total net repositioning charge
433

 
520

 
491

Asbestos related litigation charges, net of insurance and reimbursements
42

 
163

 
159

Probable and reasonably estimable environmental liabilities, net of reimbursements
59

 
345

 
287

Other
12

 
63

 
36

Total net repositioning and other charges
$
546

 
$
1,091

 
$
973


The following table summarizes the pre-tax distribution of total net repositioning and other charges by classification:
 
Years Ended December 31,
2019
 
2018
 
2017
Cost of products and services sold
$
276

 
$
811

 
$
736

Selling, general and administrative expenses
270

 
239

 
187

Other (income) expense

 
41

 
50

 
$
546

 
$
1,091

 
$
973


The following table summarizes the pre-tax impact of total net repositioning and other charges by segment:
 
Years Ended December 31,
2019
 
2018
 
2017
Aerospace
$
33

 
$
154

 
$
248

Honeywell Building Technologies
108

 
111

 
78

Performance Materials and Technologies
93

 
191

 
102

Safety and Productivity Solutions
71

 
133

 
51

Corporate
241

 
502

 
494

 
$
546

 
$
1,091

 
$
973


In 2019, the Company recognized repositioning charges totaling $438 million including severance costs of $260 million related to workforce reductions of 5,336 manufacturing and administrative positions across our segments. The workforce reductions related to costs savings actions taken in connection with our productivity and ongoing functional transformation initiatives and to site transitions, mainly in Honeywell Building Technologies, as we transition manufacturing to more cost-effective locations. The repositioning charge included asset impairments of $95 million largely related to a write down in connection with assets held for sale. The repositioning charge included exit costs of $83 million primarily related to current period exit costs incurred for previously approved repositioning projects, termination fees associated with the early cancellation of supply agreements for certain raw materials in Performance Materials and Technologies and Honeywell Building Technologies and for closure obligations associated with site transitions.
In 2018, the Company recognized repositioning charges totaling $530 million including severance costs of $289 million related to workforce reductions of 6,486 manufacturing and administrative positions across our segments. The workforce reductions were primarily related to planned site closures, mainly in Safety and Productivity Solutions, Performance Materials and Technologies and Honeywell Building Technologies, as we transition manufacturing sites to more cost-effective locations. The workforce reductions were also related to our productivity and ongoing functional
transformation initiatives. The repositioning charge included asset impairments of $162 million mainly related to manufacturing plant and equipment associated with planned site closures. Asset impairments also included the write-down of a legacy property in Corporate in connection with its planned disposition and the write-off of certain capitalized assets in Corporate. The repositioning charge included exit costs of $79 million primarily related to a termination fee associated with the early cancellation of a supply agreement for certain raw materials in Performance Materials and Technologies and for closure obligations associated with planned site closures.
In 2017, the Company recognized repositioning charges totaling $507 million including severance costs of $305 million related to workforce reductions of 7,096 manufacturing and administrative positions across its segments. The workforce reductions were primarily related to cost savings actions taken in connection with our productivity and ongoing functional transformation initiatives and with site transitions, in each of our segments, to more cost-effective locations. The repositioning charge included asset impairments of $142 million principally in our Corporate segment related to the write-down of legacy properties and certain equipment in connection with their planned disposition and the write-down of a research and development facility in connection with a planned exit from such facility. The repositioning charge included exit costs of $60 million principally for closure obligations associated with site transitions in each of our segments and for lease exit obligations in our Corporate segment.
The following table summarizes the status of the Company's total repositioning reserves:
 
Severance
Costs
 
Asset
Impairments
 
Exit
Costs
 
Total
Balance at December 31, 2016
$
298

 
$

 
$
33

 
$
331

Charges
305

 
142

 
60

 
507

Usage—cash
(163
)
 

 
(14
)
 
(177
)
Usage—noncash

 
(142
)
 

 
(142
)
Adjustments and reclassifications
(13
)
 

 
(10
)
 
(23
)
Foreign currency translation
15

 

 
2

 
17

Balance at December 31, 2017
442

 

 
71

 
513

Charges
289

 
162

 
79

 
530

Usage—cash
(218
)
 

 
(67
)
 
(285
)
Usage—noncash

 
(163
)
 

 
(163
)
Divestitures
(11
)
 

 
(3
)
 
(14
)
Adjustments
(8
)
 
1

 
(3
)
 
(10
)
Foreign currency translation
(5
)
 

 

 
(5
)
Balance at December 31, 2018
489

 

 
77

 
566

Charges
260

 
95

 
83

 
438

Usage—cash
(186
)
 

 
(63
)
 
(249
)
Usage—noncash

 
(100
)
 

 
(100
)
Divestitures

 

 

 

Adjustments
(8
)
 
5

 
(2
)
 
(5
)
Foreign currency translation

 

 
1

 
1

Balance at December 31, 2019
$
555

 
$

 
$
96

 
$
651


Certain repositioning projects will recognize exit costs in future periods when the actual liability is incurred. Such exit costs incurred in 2019, 2018 and 2017 were not significant.
In 2018, the other charge of $63 million mainly relates to reserves taken due to the required wind-down of the Company's activities in Iran and the evaluation of potential resolution of a certain legal matter.